Sun, Oct 27, 2024
Piramal Pharma is utilising a capex of about $85 million for various initiatives, including capacity expansion, maintenance and de-bottlenecking of CDMO sites, in the current fiscal, according to its Chairperson Nandini Piramal.
More >
Wed, Oct 19, 2022
Piramal Pharma made good stock market debut amid volatility in the market. Watch exclusive conversation with Ajay Piramal, Chairman, Piramal Group and Nandini Piramal, Chairperson, Piramal Pharma.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
